Company: RGBP
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001641172-25-012619
Chunk: 14

Company: Regen BioPharma Inc
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
600,000 0.0001

Series
A Preferred Stock

On
January 15, 2015 the Company filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”) with the Nevada Secretary
of State setting forth the preferences rights and limitations of a newly authorized series of preferred stock designated and known as
“ Series A Preferred Stock” (hereinafter referred to as “ Series A Preferred Stock”).

The
Board of Directors of the Company have authorized 739,000,000 0.0001

Holders
of the Series A Preferred Stock will be entitled to receive, when, as and if declared by the board of directors of the Company (the “ Board”)
out of funds legally available therefore, non-cumulative cash dividends of $ 0.01

Upon
any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary (collectively, a “ Liquidation”),
before any distribution or payment shall be made to any of the holders of Common Stock or any other series of preferred stock, the holders
of Series A Preferred Stock shall be entitled to receive out of the assets of the Company, whether such assets are capital, surplus or
earnings, an amount equal to $ 0.01

If,
upon any Liquidation, the assets of the Company shall be insufficient to pay the Liquidation Amount, together with declared and unpaid
dividends thereon, in full to all holders of Series A Preferred, then the entire net assets of the Company shall be distributed among
the holders of the Series A Preferred, ratably in proportion to the full amounts to which they would otherwise be respectively entitled
and such distributions may be made in cash or in property taken at its fair value (as determined in good faith by the Board), or both,
at the election of the Board.

On
January 10, 2017 Regen Biopharma, Inc. (“ Regen”) filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”)
with the Nevada Secretary of State setting forth the preferences rights and limitations of a newly authorized series of preferred stock
designated and known as “ Series M Preferred Stock” (hereinafter referred to as “ Series M Preferred Stock”).

The
Board of Directors of Regen have authorized 60,000,000 0.0001

The
holders of Series M Preferred Stock shall be entitled receive dividends, when, as and if declared by the Board of Directors in accordance
with Nevada